Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Yorkshire Terriers with Colour Dilution Alopecia have reduced melanin and hair structure issues.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Dendrobium candidum polysaccharides promote hair growth.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

CCCA is a common, scarring hair loss in Black women that needs early detection.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

DCPA commonly affects males' lower legs, showing follicular pustules and white areas.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The new method is rapid, sensitive, and accurate for evaluating the quality of the medicinal herb Platycladi cacumen.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.